Loading insider details...
Beta
Latest Form 4 (Jul 16, 2026): Grant/Award of 23,029 PCVX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Vaxcyte, Inc. (PCVX) | Grant/Award | 23,029 | n/a |
| Jun 15, 2026 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 15,000 | n/a |
| Jun 16, 2025 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 25,000 | n/a |
| Jun 12, 2025 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 15,000 | n/a |
| Jun 19, 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | Exercise/Conversion | 3,131 | n/a |
| Jun 6, 2024 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 25,000 | n/a |
| Aug 3, 2023 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 11,869 | n/a |
| Jun 5, 2023 | SANGAMO THERAPEUTICS, INC (SGMO) | Grant/Award | 13,900 | n/a |
| Dec 13, 2022 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 20,000 | n/a |
| Jun 6, 2022 | SANGAMO THERAPEUTICS, INC (SGMO) | Purchase | 6,784 | $25.0K |